Si Wang
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
Papers in
-
- Blood Pressure and Hypertension Studies 6
- Heart Failure Treatment and Management 5
- Cardiovascular Health and Disease Prevention 4
- Heart Rate Variability and Autonomic Control 4
- Cardiovascular Function and Risk Factors 4
- Surgery 10
- Cardiac Structural Anomalies and Repair 3
- Co-authors
- Sen He (6 shared papers)Di Shi (5 shared papers)Xiaoping Chen (6 shared papers)Yong Peng (4 shared papers)Kai Liu (10 shared papers)Longxin Li (3 shared papers)Xiaoping Chen (5 shared papers)Liyan Wan (2 shared papers)
- Journals
- BMC Cardiovascular Disorders (4 papers)Frontiers in Pharmacology (3 papers)Cardiovascular Diabetology (2 papers)Internal and Emergency Medicine (2 papers)Frontiers in Cardiovascular Medicine (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Si Wang
45 papers receiving 507 citations
Peers
Comparison fields: 5 of 106
- Endocrinology, Diabetes and Metabolism 174
- Cardiology and Cardiovascular Medicine 176
- Family Practice 7
- Physiology 76
- Epidemiology 101
Countries citing papers authored by Si Wang
This map shows the geographic impact of Si Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Wang more than expected).
Fields of papers citing papers by Si Wang
This network shows the impact of papers produced by Si Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Wang. The network helps show where Si Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Si Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 75 | |
| 2 | 2022 | 51 | |
| 3 | 2017 | 50 | |
| 4 | 2018 | 38 | |
| 5 | 2022 | 34 | |
| 6 | 2012 | 25 | |
| 7 | Irisin attenuates H2O2-induced apoptosis in cardiomyocytes via microRNA-19b/AKT/mTOR signaling pathway. | 2017 | 23 |
| 8 | 2014 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2011 | 14 | |
| 11 | 2023 | 14 | |
| 12 | 2015 | 14 | |
| 13 | 2023 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2024 | 10 | |
| 16 | 2007 | 10 | |
| 17 | 2018 | 9 | |
| 18 | 2015 | 9 | |
| 19 | Hypercholesterolemia Up-Regulates the Expression of Intermedin and Its Receptor Components in the Aorta of Rats via Inducing the Oxidative Stress. | 2016 | 9 |
| 20 | 2020 | 7 |
About Si Wang
Si Wang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology, having authored 52 papers that have together received 521 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (6 papers), Heart Failure Treatment and Management (5 papers), Cardiovascular Health and Disease Prevention (4 papers), Heart Rate Variability and Autonomic Control (4 papers), Cardiovascular Function and Risk Factors (4 papers), Cardiac Structural Anomalies and Repair (3 papers), Diabetes Treatment and Management (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (174 citations), Cardiology and Cardiovascular Medicine (176 citations), Family Practice (7 citations), Physiology (76 citations) and Epidemiology (101 citations). Si Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Sen He, Di Shi, Xiaoping Chen, Yong Peng, Kai Liu, Longxin Li, Xiaoping Chen, Liyan Wan, Qingtao Meng and Rufeng Shi. Their work appears in journals such as BMC Cardiovascular Disorders, Frontiers in Pharmacology, Cardiovascular Diabetology, Internal and Emergency Medicine and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.